Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells.
Obesity is a significant risk factor for certain cancers, including hepatocellular carcinoma (HCC). Leptin, a hormone secreted by white adipose tissue, precipitates HCC development. Epidemiology data show that men have a much higher incidence of HCC than women, suggesting that estrogens and its rece...
Main Authors: | Minqian Shen, Haifei Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4794158?pdf=render |
Similar Items
-
Effects of Estrogen and Estrogen Receptors on Transcriptomes of HepG2 Cells: A Preliminary Study Using RNA Sequencing
by: Minqian Shen, et al.
Published: (2018-01-01) -
A Multi-Omics Study Revealing the Metabolic Effects of Estrogen in Liver Cancer Cells HepG2
by: Minqian Shen, et al.
Published: (2021-02-01) -
The differential genomic studies in the HepG2/A2 with the treatment of 17 B-estradiol
by: Chia-Lun Chang, et al.
Published: (2002) -
Roles of estrogen hormones and estrogen receptors on regulation of liver and liver cancer metabolism
by: Shen, Minqian
Published: (2017) -
17β-Estradiol promotes the up-regulation of SR-BII in HepG2 cells and in rat livers
by: Gregory A. Graf, et al.
Published: (2001-09-01)